Cargando…

DNA methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘DKFZ Sarcoma Classifier’

Diagnosing bone and soft tissue neoplasms remains challenging because of the large number of subtypes, many of which lack diagnostic biomarkers. DNA methylation profiles have proven to be a reliable basis for the classification of brain tumours and, following this success, a DNA methylation‐based sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyskjær, Iben, De Noon, Solange, Tirabosco, Roberto, Rocha, Ana Maia, Lindsay, Daniel, Amary, Fernanda, Ye, Hongtao, Schrimpf, Daniel, Stichel, Damian, Sill, Martin, Koelsche, Christian, Pillay, Nischalan, Von Deimling, Andreas, Beck, Stephan, Flanagan, Adrienne M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185366/ https://www.ncbi.nlm.nih.gov/pubmed/33949149 http://dx.doi.org/10.1002/cjp2.215

Ejemplares similares

MYC amplifications are common events in childhood osteosarcoma
por: De Noon, Solange, et al.
Publicado: (2021)

H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours
por: Lyskjær, Iben, et al.
Publicado: (2020)

Sarcoma and the 100,000 Genomes Project: our experience and changes to practice
por: Prendergast, Sophie C, et al.
Publicado: (2020)

Drivers underpinning the malignant transformation of giant cell tumour of bone
por: Fittall, Matthew W, et al.
Publicado: (2020)

Frequent alterations in p16/CDKN2A identified by immunohistochemistry and FISH in chordoma
por: Cottone, Lucia, et al.
Publicado: (2020)

A genetic model for central chondrosarcoma evolution correlates with patient outcome
por: Cross, William, et al.
Publicado: (2022)

Synovial chondromatosis and soft tissue chondroma: extra-osseous cartilaginous tumours defined by FN1 gene rearrangement
por: Amary, Fernanda, et al.
Publicado: (2019)

Clinical outcome in patients with peripherally‐sited atypical lipomatous tumours and dedifferentiated liposarcoma
por: Kalimuthu, Sangeetha N, et al.
Publicado: (2015)

Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways
por: Steele, Christopher D., et al.
Publicado: (2019)

Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy
por: Fernanda Amary, M, et al.
Publicado: (2014)

Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimics
por: Presneau, Nadège, et al.
Publicado: (2015)

Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype
por: Koelsche, Christian, et al.
Publicado: (2019)

Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas
por: Amary, M. Fernanda, et al.
Publicado: (2014)

Recurrent FOSL1 rearrangements in desmoplastic fibroblastoma
por: De Noon, Solange, et al.
Publicado: (2023)

H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone
por: Amary, Fernanda, et al.
Publicado: (2017)

Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection
por: Gutteridge, Alice, et al.
Publicado: (2017)

ProtSweep, 2Dsweep and DomainSweep: protein analysis suite at DKFZ
por: del Val, C., et al.
Publicado: (2007)

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology
por: Mock, Andreas, et al.
Publicado: (2023)

LGG-33. ISOMORPHIC DIFFUSE GLIOMA HAS RECURRENT GENE FUSIONS OF MYBL1 OR MYB AND CAN BE DISTINGUISHED FROM OTHER MYB/MYBL1 ALTERED GLIOMAS BASED ON A DISTINCT MORPHOLOGY AND DNA METHYLATION PROFILE
por: Wefers, Annika K, et al.
Publicado: (2020)

EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
por: Scheipl, Susanne, et al.
Publicado: (2016)

Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications
por: Kommoss, Felix KF, et al.
Publicado: (2020)

Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature
por: Koelsche, Christian, et al.
Publicado: (2021)

PATH-26. RNA SEQUENCING OF FORMALIN-FIXED PARAFFIN-EMBEDDED SPECIMENS IN DIAGNOSTIC ROUTINE IDENTIFIES CLINICALLY RELEVANT GENE FUSIONS
por: Stichel, Damian, et al.
Publicado: (2020)

Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations
por: Lyskjær, Iben, et al.
Publicado: (2021)

Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
por: Capper, David, et al.
Publicado: (2018)

Recurrent rearrangements of FOS and FOSB define osteoblastoma
por: Fittall, Matthew W., et al.
Publicado: (2018)

Multifocal osteoclast-rich tumour in Paget bone disease and conventional giant cell tumour, two genetically distinct entities? Sequencing from a single case
por: Haefliger, Simon, et al.
Publicado: (2023)

Post-translational regulation contributes to the loss of LKB1 expression through SIRT1 deacetylase in osteosarcomas
por: Presneau, Nadège, et al.
Publicado: (2017)

PATH-04. AN ENHANCED AI-DRIVEN PLATFORM FOR PRECISION MOLECULAR BRAIN TUMOR DIANOSTICS
por: Sill, Martin, et al.
Publicado: (2020)

Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression
por: Korshunov, Andrey, et al.
Publicado: (2022)

Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts
por: Yang, Lingjian, et al.
Publicado: (2017)

Clinical implementation of integrated molecular‐morphologic risk prediction for meningioma
por: Hielscher, Thomas, et al.
Publicado: (2022)

Development of a Single Vial Kit Solution for Radiolabeling of (68)Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients
por: Ebenhan, Thomas, et al.
Publicado: (2015)

Therapeutic response and side effects of repeated radioligand therapy with (177)Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer
por: Ahmadzadehfar, Hojjat, et al.
Publicado: (2016)

Correction: Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts
por: Yang, Lingjian, et al.
Publicado: (2019)

Comparison of Accuracy in Calculation of Absorbed Dose to the Kidneys Following Radioligand Therapy with (177)Lu-DKFZ-PSMA-617 by Two Different Background Correction Methods
por: Mahmoudi, Elahe, et al.
Publicado: (2022)

Optimizing the cancer research landscape for the benefit of patients and society: A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical centers
por: Baumann, Michael
Publicado: (2022)

Sarcoma classification by DNA methylation profiling
por: Koelsche, Christian, et al.
Publicado: (2021)

Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
por: Guilhamon, Paul, et al.
Publicado: (2013)

Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre
por: Jaunmuktane, Zane, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ddutj7cktufg78qdm8tliasnt8